Cargando…
Cardio-renal benefits of sacubitril/valsartan in patients with advanced chronic kidney disease: experience in daily clinical practice
BACKGROUND: The association between cardiac complications, such as heart failure (HF), and chronic kidney disease (CKD) is well known. In this study, we examined the effectiveness and safety of treatment with neprilysin inhibition in patients with advanced chronic kidney disease (stage 3b-4). METHOD...
Autores principales: | Martínez-Esteban, María Dolores, Vázquez-Sánchez, Teresa, Pozo-Álvarez, Rafael, Moreno-Ortiz, Alicia, Alonso-Titos, Juana, Martín-Reyes, Guillermo, Ruiz-Esteban, Pedro, Gaitán-Román, Daniel, Hernández, Domingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396870/ https://www.ncbi.nlm.nih.gov/pubmed/35999504 http://dx.doi.org/10.1186/s12882-022-02919-z |
Ejemplares similares
-
Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
por: Gregorietti, Vanesa, et al.
Publicado: (2020) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Sacubitril/Valsartan Shows Improvement of the Cardio-Ankle Vascular Index in a Hypertensive Patient
por: Shimizu, Kazuhiro, et al.
Publicado: (2023) -
Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
por: Pascual-Figal, Domingo, et al.
Publicado: (2021) -
Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)